These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36518577)

  • 1. The impacts of COVID-19 on China insurance industry-An empirical analysis based on event study.
    Wu X; Wang C; Wen HX; Nie PY; Ye JF
    Front Public Health; 2022; 10():1033863. PubMed ID: 36518577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Impacts of COVID-19 on the Industrial Sectors and Economy of China.
    Tan L; Wu X; Guo J; Santibanez-Gonzalez EDR
    Risk Anal; 2022 Jan; 42(1):21-39. PubMed ID: 34448216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.
    Wu J; Qiao J; Nicholas S; Liu Y; Maitland E
    BMC Health Serv Res; 2022 Sep; 22(1):1189. PubMed ID: 36138390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research on Monetary Policy Implementation and Industrial Structure Transformation Under COVID-19-Evidence From Eight Economic Zones in Mainland China.
    Zhou B; Wang S; Gao H; Wang H
    Front Public Health; 2022; 10():865699. PubMed ID: 35669741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic-Based on Cases of Dominant Listed Companies.
    Ye R; An N; Xie Y; Luo K; Lin Y
    Front Public Health; 2021; 9():663189. PubMed ID: 34041217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the COVID-19 epidemic on medical product imports from china from outbreak to stabilization: Monthly panel data regression and instrumental variable test.
    Pu Y; Xu A; Wang H; Qian F
    Front Public Health; 2023; 11():1115650. PubMed ID: 36844833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the influence of COVID-19 on the growth of China's small and medium-sized construction enterprises.
    Wang W; Lin W; Bao Z; Dai X; Lin Q
    PLoS One; 2022; 17(6):e0266315. PubMed ID: 35657961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.
    Li M
    Glob Public Health; 2021; 16(8-9):1223-1236. PubMed ID: 33891518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supply chain concentration and enterprise financialization: Evidence from listed companies in China's manufacturing industry.
    He H; Zuo Z
    PLoS One; 2023; 18(5):e0285308. PubMed ID: 37163518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How China controls the Covid-19 epidemic through public health expenditure and policy?
    Jin H; Li B; Jakovljevic M
    J Med Econ; 2022; 25(1):437-449. PubMed ID: 35289700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Digital Transformation Promote the Rapid Recovery of Cities from the COVID-19 Epidemic? An Empirical Analysis from Chinese Cities.
    Liu J; Liu S; Xu X; Zou Q
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing social security contribution rate on the financial performance of state-owned and non-state-owned manufacturing industries in the post-epidemic era.
    Zhang L; Yang G
    PLoS One; 2023; 18(6):e0287596. PubMed ID: 37352277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of COVID-19 on Consumers' Psychological Behavior Based on Data Mining for Online User Comments in the Catering Industry in China.
    Zhang C; Jiang J; Jin H; Chen T
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic risk spillover effect and path of risk transmission across industrial sectors in China during COVID-19 epidemic.
    Ling L; Khan H; Lingwei J; Qiumei L; Zuominyang Z; Khan I
    PLoS One; 2023; 18(10):e0292859. PubMed ID: 37831727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research on the Integration of Cultural Tourism Industry Driven by Digital Economy in the Context of COVID-19-Based on the Data of 31 Chinese Provinces.
    Li X; Liang X; Yu T; Ruan S; Fan R
    Front Public Health; 2022; 10():780476. PubMed ID: 35356017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on the influence of the COVID-19 epidemic on work stress of returning workers in China: A study based on empirical analyses of industrial enterprises.
    Yang Q; Huo J; Li J; Jiang Y
    Work; 2020; 67(1):67-79. PubMed ID: 32955475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Business Model Innovation Paths of Manufacturing Oriented towards Green Development in Digital Economy.
    Han X; Zhang J
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of the COVID-19 Pandemic on Consumer Behavior-Evidence From China's Stock Market.
    Lu Z; Zhu L; Li X; Li Z
    Front Public Health; 2022; 10():865470. PubMed ID: 36148367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovation Model of China's High-End Equipment Industry: Do Social Capital and Dynamic Capabilities Matter for the COVID-19 Crisis?
    Ai Y; Peng D
    Front Public Health; 2021; 9():683120. PubMed ID: 34164374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of China's live streaming e-commerce industry policies based on a three-dimensional analysis framework.
    Wang B; Tong C; Chen T; Yang J; Cong G
    PLoS One; 2024; 19(5):e0301451. PubMed ID: 38743650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.